Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Therma Bright Inc V.THRM

Alternate Symbol(s):  TBRIF

Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. Its products include Benepod, Inretio, AI4LYF, Invixa and Instatin, and others.


TSXV:THRM - Post by User

Comment by Watchman21on Aug 17, 2022 8:35am
147 Views
Post# 34901506

RE:Please Don't Throw Rocks At Me They Will Hurt !!!

RE:Please Don't Throw Rocks At Me They Will Hurt !!!November 2021 was US Performance Study complete February 2022z. Health Canada has a type of reciprocity agreement for clinical studies done outside Canada with favored nations like US, so long as certain protocols were followed,  

In the interim, Health Canada is reminding sponsors of its expectation that the clinical studies submitted in support of a Canadian market authorization were conducted in accordance with internationally recognized Good Clinical Practice standards that guide the ethical and scientific conduct of clinical research.

This Notice applies to submissions for all product lines, specifically:

  1. medical device licence applications subject to the Medical Devices Regulations;


Obviously THRM followed those International Standard for a good clinical study . Therefore l, those US clinical results are being used for HC Interim Order #3 application.

Click this link below for further information around HC and outside Canada studies.  

https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/announcements/submissions-containing-clinical-data-studies-conducted-outside-canada.html
<< Previous
Bullboard Posts
Next >>